drugset / Trial / NCT04697654
The Safety, Tolerability, and Pharmacokinetics of Inhaled TLC19 in Healthy Volunteers
RandomizedSequentialQuadruple-blindTreatment
Summary
Phase 1 randomized, vehicle-controlled, blinded study to assess the safety, tolerability, and PK of single ascending doses of inhaled TLC19 in healthy volunteer subjects.
Timeline
- Start
- 2020-10-08
- Primary completion
- 2021-06-18
- Completion
- 2021-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TLC19 | Unknown | 2 ml | Inhaled |
| Subject | TLC19 | Unknown | 4 ml | Inhaled |
| Subject | TLC19 | Unknown | 6 ml | Inhaled |